Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

Alamar Biosciences, Inc. (ALMR) had Cash Flow from Financial Activities of 55.76M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	26.04M
Net Income	-21.32M
Cost of Goods Sold	11.58M
Gross Profit	14.46M
Operating Expenses	38.38M
Operating Income	-12.35M
Non-Operating Income/Expense	-8.51M
Pre-Tax Income	-20.86M
Normalized Pre-Tax Income	-20.86M
Income after Taxes	-21.32M
Income from Continuous Operations	-21.32M
Consolidated Net Income/Loss	-21.32M
Normalized Income after Taxes	-21.32M
EBIT	-12.35M
EBITDA	-11.11M
Weighted-Average Shares Outstanding (Basic)	12.26M
Weighted-Average Shares Outstanding (Diluted)	12.26M
Earnings per Share (EPS) (Basic)	-1.74
Earnings per Share (EPS) (Diluted)	-1.74
Balance Sheet Financials
Current Assets	141.47M
Property, Plant, and Equipment	10.47M
Long-Term Assets	44.98M
Total Assets	186.45M
Current Liabilities	24.05M
Long-Term Debt	74.97M
Long-Term Liabilities	105.48M
Total Liabilities	129.53M
Common Equity	-178.07M
Tangible Shareholders Equity	55.09M
Shareholders Equity	56.92M
Common Shares Outstanding	12.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	-20.35M
Cash Flow from Investing Activities	-0.78M
Cash Flow from Financial Activities	55.76M
Beginning Cash	34.91M
End Cash	69.49M
Increase/Decrease in Cash	34.58M
Stock-Based Compensation	1.47M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.57
Debt to Equity Ratio	1.32
Gross Margin	55.53%
Operating Margin	-47.42%
EBIT Margin	-47.42%
EBITDA Margin	--
Pre-Tax Profit Margin	-80.13%
Profit Margin	-81.91%
Free Cash Flow	-20.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.29
Receiveable Turnover	1.33
Days Sales in Receivables	67.49
Return on Equity	11.98%
Return on Tangible Equity	-38.71%
Return on Assets	-11.44%
Return on Investments	-16.17%
Book Value Per Share	4.42
Free Cash Flow per Share	-1.71
Operating Cash Flow per Share	-1.66

Data from Zacks Investment Research, Inc.